Braxia Scientific Correlations
| BRAXF Stock | USD 0 0 50.00% |
The current 90-days correlation between Braxia Scientific Corp and Enlivex Therapeutics is -0.05 (i.e., Good diversification). The correlation of Braxia Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Braxia Scientific Correlation With Market
Good diversification
The correlation between Braxia Scientific Corp and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Braxia Scientific Corp and DJI in the same portfolio, assuming nothing else is changed.
Braxia |
The ability to find closely correlated positions to Braxia Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Braxia Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Braxia Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Braxia Scientific Corp to buy it.
Moving against Braxia Pink Sheet
| 0.59 | QSAM | Qsam Biosciences | PairCorr |
| 0.5 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.45 | NIHK | Video River Networks | PairCorr |
| 0.43 | NVO | Novo Nordisk AS | PairCorr |
| 0.43 | CMXHF | CSL Limited | PairCorr |
| 0.4 | NONOF | Novo Nordisk AS | PairCorr |
| 0.4 | CSLLY | CSL | PairCorr |
| 0.38 | SGEN | Seagen Inc | PairCorr |
| 0.37 | GLUC | Glucose Health | PairCorr |
| 0.5 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.48 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.43 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.39 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Braxia Pink Sheet performing well and Braxia Scientific Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Braxia Scientific's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SBHMY | 0.62 | 0.19 | 0.00 | 1.33 | 0.00 | 0.00 | 25.86 | |||
| DTCFF | 1.04 | (0.17) | 0.00 | (1.58) | 0.00 | 0.00 | 25.87 | |||
| ALRN | 4.44 | (0.23) | 0.00 | (0.34) | 0.00 | 9.81 | 41.47 | |||
| ENLV | 3.42 | (0.36) | 0.00 | (0.53) | 0.00 | 9.03 | 26.52 | |||
| LVCLF | 1.99 | (0.33) | 0.00 | 0.70 | 0.00 | 0.00 | 66.02 | |||
| MCET | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HESG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MYMX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MRZM | 8.35 | 1.58 | 0.04 | (0.42) | 10.23 | 25.00 | 128.57 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Braxia Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Braxia Scientific Corporate Management
| Joshua Rosenblat | Chief Officer | Profile | |
| Roger McIntyre | Chairman CEO | Profile | |
| Stephen Brooks | Chief Officer | Profile | |
| Peter Rizakos | G Counsel | Profile | |
| Jason Wolkove | Chief Officer | Profile |